Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Quinapril. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE known ✓ | P12821 | 15/20 | 0.79 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.79 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinapril SCHEMBL29380303 | 0.89 | ACE (1.00) | ACEABCB11PDE3ALMNA | |
| Quinapril SCHEMBL29846170 | 0.89 | ACE (1.00) | ACEABCB11PDE3ALMNA | |
| Quinapril SCHEMBL13575806 | 0.89 | ACE (1.00) | ACEABCB11PDE3ALMNA | |
| Quinapril SCHEMBL11294979 | 0.89 | ACE (1.00) | ACEABCB11PDE3ALMNA | |
| Quinapril SCHEMBL11286555 | 0.89 | ACE (1.00) | ACEABCB11PDE3ALMNA | |
| Quinapril SCHEMBL9094436 | 0.89 | ACE (1.00) | ACEABCB11PDE3ALMNA | |
| Quinapril SCHEMBL19361887 | 0.89 | ACE (1.00) | ACEABCB11PDE3ALMNA | |
| Quinapril SCHEMBL678447 | 0.89 | ACE (1.00) | ACEABCB11PDE3ALMNA | |
| Quinapril SCHEMBL994608 | 0.89 | ACE (1.00) | ACEABCB11PDE3ALMNA | |
| Quinapril SCHEMBL15813 | 0.89 | ACE (1.00) | ACEABCB11PDE3ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080234373-A1 | Compound Useful For the Prevention and Treatment of Left Ventricular Hypertrophy in Dialysed Patients | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2008-09-25 | — | — | US | claimed |